HSPs and autologous tumor antigen polypeptides can form complexes, named HSP-peptide complexes (HSPPCs), to mediate cell endocytosis and antigen presentation by binding to APC membrane receptors, activating CD4+ and CD8+ T cells and triggering immune responses against tumor antigen peptides [92]. The gene discussed is CD4; the disease is neoplasm.